4.6 Article

Therapeutic Trial of Metformin and Bortezomib in a Mouse Model of Tuberous Sclerosis Complex (TSC)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

mTOR links oncogenic signaling to tumor cell metabolism

Jessica L. Yecies et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2011)

Review Cell Biology

mTOR: from growth signal integration to cancer, diabetes and ageing

Roberto Zoncu et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)

Article Medicine, General & Internal

Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis

Francis X. McCormack et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Multidisciplinary Sciences

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

Peter Walter et al.

SCIENCE (2011)

Editorial Material Oncology

Chemoprevention Meets Glucose Control

Jeffrey A. Engelman et al.

CANCER PREVENTION RESEARCH (2010)

Article Oncology

Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis

Regan M. Memmott et al.

CANCER PREVENTION RESEARCH (2010)

Article Biochemistry & Molecular Biology

Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation

Chunyang Li et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Medicine, General & Internal

Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis.

Darcy A. Krueger et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Biochemistry & Molecular Biology

Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis

Kristen Pollizzi et al.

MOLECULAR CANCER (2009)

Review Biochemistry & Molecular Biology

The TSC1-TSC2 complex: a molecular switchboard controlling cell growth

Jingxiang Huang et al.

BIOCHEMICAL JOURNAL (2008)

Article Biochemistry & Molecular Biology

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

Xu Huang et al.

BIOCHEMICAL JOURNAL (2008)

Article Biochemistry & Molecular Biology

AMPK phosphorylation of raptor mediates a metabolic checkpoint

Dana M. Gwinn et al.

MOLECULAR CELL (2008)

Article Medicine, General & Internal

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

John J. Bissler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Oncology

Defining the role of mTOR in cancer

David A. Guertin et al.

CANCER CELL (2007)

Review Oncology

Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies

Tommaso Caravita et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2006)

Article Clinical Neurology

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

DN Franz et al.

ANNALS OF NEUROLOGY (2006)

Review Biochemistry & Molecular Biology

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways

DJ Kwiatkowski et al.

HUMAN MOLECULAR GENETICS (2005)

Article Pediatrics

Effects of rapamycin in the Eker rat model of tuberous sclerosis complex

H Kenerson et al.

PEDIATRIC RESEARCH (2005)

Article Biochemistry & Molecular Biology

TSC2 mediates cellular energy response to control cell growth and survival

K Inoki et al.